Showing results (1-10 of 227) with videos related to
Sort By:
Pageof 23
STAR Protocols|December 16, 2023
Protocol for producing an adeno-associated virus vector by controlling capsid expression timingKenji Ohba, Hiroaki MizukamiIscience|April 25, 2023
Adeno-associated virus vector system controlling capsid expression improves viral quantity and qualityKenji Ohba, Yoshihide Sehara, Tatsuji Enoki, et al.Human Gene Therapy|May 19, 2025
Limitation of Assay Sensitivity Revealed by the Improvement of Cell-Based Assay Against Various Adeno-Associated Virus SerotypesRyota Watano, Kenji Ohba, Yoshihide Sehara, et al.Human Gene Therapy|February 22, 2024
Therapeutic Strategy for Fabry Disease by Intravenous Administration of Adeno-Associated Virus 9 in a Symptomatic Mouse ModelYuka Hayashi, Yoshihide Sehara, Ryota Watano, et al.Molecular Neurobiology|April 27, 2024
Adeno-associated Virus-mediated Ezh2 Knockdown Reduced the Increment of Newborn Neurons Induced by Forebrain Ischemia in Gerbil Dentate GyrusYoshihide Sehara, Yuki Hashimotodani, Ryota Watano, et al.The Journal of Gene Medicine|July 1, 2023
Therapeutic strategy for Fabry disease by intravenous administration of adeno-associated virus 2 or 9 in α-galactosidase A-deficient miceYuka Hayashi, Yoshihide Sehara, Ryota Watano, et al.Human Gene Therapy|August 5, 2021
Higher Transduction Efficiency of AAV5 to Neural Stem Cells and Immature Neurons in Gerbil Dentate Gyrus Compared to AAV2 and rh10Yoshihide Sehara, Yuka Hayashi, Kenji Ohba, et al.International Journal of Molecular Sciences|July 2, 2021
An Update on the Pathophysiology and Diagnosis of Inappropriate Secretion of Thyroid-Stimulating HormoneKenji OhbaYakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2006
[Utility of AAV vectors derived from novel serotypes]Hiroaki Mizukami, Keiya OzawaEndocrine Journal|July 24, 2022
Role of thyroid hormone in an experimental model of atherosclerosis: the potential mediating role of immune response and autophagyKenji Ohba, Takayuki IwakiPageof 23